Table 5:

Data collection in programs performing LT for AH

Timing	Main component	Sub component
Pretransplant	AH	definite, probable, possible
	Number with AH
	Number evaluated
	Number listed
	Medical and psychosocial Characteristics of evaluated not listed vs listed	Gender, race, MELD, insurance
	Medical treatment	Steroids, other
	Contraindication or ineligible for steroids	Disease severity Multiorgan failure
	Accurate coding for AH
	AUD diagnosis	Mild, moderate, severe
	Prior AUD treatment	Types of AUD treatment previously used
	Explant and Biopsy characteristics
	Comorbid psychiatric and/or substance use disorders
	Other substance use
Transplant	Multidisciplinary Team assessment	Addiction specialist Social Worker mental health professional
	Routine Testing	Alcohol biomarker testing: Phosphatidylethanol (PEth), Urinary ethyl glucuronide
	Pattern of alcohol use	Slip, relapse, heavy
Post LT	Documentation of AUD management plan pre and post-LT required
	Documentation of EtG or PEtH testing
	Survival 1, 3 5 years